FGF23, a novel muscle biomarker detected in the early stages of ALS

FGF23, a novel muscle biomarker detected in the early stages of ALS

Abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive muscle weakness. Skeletal muscle is a prime source for biomarker discovery since it is one of the earliest sites to manifest disease pathology. From a prior RNA sequencing project, we ident...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ying Si, Mohamed Kazamel, Michael Benatar, Joanne Wuu, Yuri Kwon, Thaddaeus Kwan, Nan Jiang, Dominik Kentrup, Christian Faul, Lyndsy Alesce, Peter H. King
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/0f8008a5ad874d87a61a78f2f91ba8e9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares